Found 363 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
Multi-Method Health System Quality Improvement Intervention to Reduce Hypertension Disparities
NAThe investigators have designed a three-part quality improvement interventi...
Location
Johns Hopkins Community Physicians
Research on Intelligent Screening and Decision-making for Neoadjuvant Therapy in Locally Advanced Gastric Cancer Based on Multi-omics Integration
N/AIn this study, investigators utilize a radiopathomics integrated Artificial...
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis
PHASE4The goal of the study is to evaluate strategies that target the microbiota ...
Location
The Children's Hospital of Philadelphia
A Comparison of Two Different Treatment Approaches for Adolescents With Osgood Schlatter
NAThe most common growth-related injury is Osgood Schlatter, which affects up...
Location
Hvidovre Hospital
Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
PHASE3ACTT-2 will evaluate the combination of baricitinib and remdesivir compared...
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer
PHASE2This phase II clinical trial is evaluating whether adding KRC-01 injections...
Enduring Happiness and Continued Self-Enhancement (ENHANCE) for COVID-19
NAThis study is a randomized controlled trial of an online, evidenced-based i...
Location
University of British Columbia
New Technology to Assess Treatment for Chronic Obstructive Pulmonary Disease (COPD)
EARLY_PHASE1First, the investigators will image patients with hyperpolarized xenon (Xe)...
Location
University of Virginia
GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies
PHASE1This is a multi-center Phase I/II clinical trial of GTB-3550 (CD16/IL-15/CD...
Location
Masonic Cancer Center, University of Minnesota